Normec Enters U.S., Acquires MS Bio, M.J. Reider and NorthEast BioLab
August 6, 2025
Normec, the Astorg-backed European testing, inspection, certification and compliance (TICC) platform, has entered the United States by acquiring three specialized laboratories: MS Bio (Champaign, IL), M.J. Reider (Reading/near Philadelphia, PA) and NorthEast BioLab (Hamden, CT). The deals expand Normec’s capabilities across food/supplement testing, water/environmental analysis and bioanalytical/CRO services, more than doubling its addressable market in North America.
- Buyers
- Normec, Astorg
- Targets
- MS Bio, M.J. Reider, NorthEast BioLab
- Platforms
- Normec
- Industry
- Professional Services
- Location
- United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Normec Acquires Derwentside Environmental Testing Services Ltd. and Latis Scientific Ltd.
October 26, 2023
Environmental Services
Normec has acquired UK-based environmental and water testing businesses Derwentside Environmental Testing Services Ltd. and Latis Scientific Ltd., adding three laboratory locations across the UK and bolstering its environmental testing capabilities. The deal strengthens Normec's UK footprint following earlier M&A activity and retains the DETS & Latis management team led by Kirk Bridgewood.
-
US BioTek Laboratories Acquires RealTime Laboratories
March 19, 2024
Healthcare Services
US BioTek Laboratories, a Pike Street Capital portfolio company, has acquired Dallas-based RealTime Laboratories to expand its diagnostic testing capabilities, specifically mycotoxin and infectious disease testing. The deal broadens the combined organization’s services and geographic footprint while both labs continue operating at their respective locations.
-
Bruker Corporation Acquires biocrates life sciences ag
June 3, 2025
Biotechnology
Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.
-
NAMSA Acquires Perfectus Biomed Group
October 4, 2022
Medical Devices
NAMSA, a global MedTech CRO headquartered in Toledo, Ohio, has acquired Perfectus Biomed Group, a UK-based microbiological testing laboratory headquartered in Cheshire. The acquisition expands NAMSA's European laboratory services and deepens its microbiological testing and biofilm expertise to better support medical device clients; terms were not disclosed.
-
BioAgilytix Acquires 360biolabs and MicroConstants
October 14, 2021
Healthcare Services
BioAgilytix Labs, LLC acquired Australia-based 360biolabs and US-based MicroConstants to expand its global footprint and bioanalytical capabilities, including LC/MS/MS, virology and immunology expertise. The deals (360biolabs subject to FIRB approval) add capacity in Melbourne and Brisbane and establish BioAgilytix San Diego, strengthening support for first-in-human and early-phase clinical trials across major geographies.
-
Matrix Medical Network Acquires Biocerna
October 2, 2020
Healthcare Services
Matrix Medical Network acquired Biocerna, a CLIA-certified and CAP-accredited clinical laboratory based in Fulton, Maryland, to integrate in-house diagnostic and COVID-19 testing capabilities. The acquisition expands Matrix's ability to deliver timely testing services to its network of clinicians and mobile health clinics, supporting employer testing, clinical trial support, and other client-facing diagnostic services.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.